IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $660,000 | +4.9% | 12,200 | 0.0% | 0.02% | +46.7% |
| Q3 2018 | $629,000 | -12.2% | 12,200 | -29.1% | 0.02% | -16.7% |
| Q2 2018 | $716,000 | -5.5% | 17,200 | 0.0% | 0.02% | -18.2% |
| Q1 2018 | $758,000 | -12.4% | 17,200 | 0.0% | 0.02% | -12.0% |
| Q4 2017 | $865,000 | -1.9% | 17,200 | -1.1% | 0.02% | -3.8% |
| Q3 2017 | $882,000 | +0.8% | 17,400 | +1.2% | 0.03% | -10.3% |
| Q2 2017 | $875,000 | +26.6% | 17,200 | 0.0% | 0.03% | +31.8% |
| Q1 2017 | $691,000 | -16.0% | 17,200 | 0.0% | 0.02% | -18.5% |
| Q4 2016 | $823,000 | +30.6% | 17,200 | 0.0% | 0.03% | +50.0% |
| Q3 2016 | $630,000 | +57.1% | 17,200 | 0.0% | 0.02% | +80.0% |
| Q2 2016 | $401,000 | -41.7% | 17,200 | +1.2% | 0.01% | -41.2% |
| Q1 2016 | $688,000 | -34.7% | 17,000 | 0.0% | 0.02% | -26.1% |
| Q4 2015 | $1,053,000 | – | 17,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |